Liao Kang-Xiong, Yao Xue-Qing, Wu Cheng-Tang, Lin Feng, Wu Wu-Lin, Zeng Sui-de, Luo Yu-Qi, Lei Shang-Tong
Department of General Surgery, Nanfang Hosptial, Southern Medical University, Guangzhou 510515, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):986-90.
To screen the polypeptides specifically binding to human large intestinal cancer LoVo cells from a phage-displayed peptide library for potential use as targeting vectors for large intestinal cancer therapy.
With the LoVo cells as the target cells and human normal large intestinal mucosal epithelial cells as the absorber cells for subtraction biopanning from a c7c phage-display peptide library, the positive phage clones were identified by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence detection. The amino acid sequences of the identified peptides were deduced by DNA sequencing.
After 3 rounds of screening, 5 positive phage clones showing specific binding to LoVo cells and containing conserved motif RPMP were obtained from the 20 randomly selected clones.
Specific peptide against large intestinal cancer cells can be obtained from a phage-display peptide library for use as potential vectors for targeting therapy of large intestinal cancer.
从噬菌体展示肽库中筛选与人大肠癌细胞LoVo特异性结合的多肽,以用作大肠癌治疗的潜在靶向载体。
以LoVo细胞为靶细胞,人正常大肠黏膜上皮细胞为吸收细胞,从c7c噬菌体展示肽库中进行减法生物淘选,通过酶联免疫吸附测定(ELISA)和免疫荧光检测鉴定阳性噬菌体克隆。通过DNA测序推导所鉴定肽的氨基酸序列。
经过3轮筛选,从20个随机选择的克隆中获得了5个与LoVo细胞特异性结合且含有保守基序RPMP的阳性噬菌体克隆。
可从噬菌体展示肽库中获得针对大肠癌细胞的特异性肽,用作大肠癌靶向治疗的潜在载体。